Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$32.18 - $46.57 $513,431 - $743,024
15,955 New
15,955 $716,000
Q2 2023

Aug 14, 2023

BUY
$31.86 - $67.26 $554,555 - $1.17 Million
17,406 New
17,406 $754,000
Q4 2022

Feb 14, 2023

SELL
$41.39 - $81.0 $878,958 - $1.72 Million
-21,236 Reduced 43.15%
27,981 $1.26 Million
Q3 2022

Nov 14, 2022

BUY
$72.36 - $113.1 $2.45 Million - $3.83 Million
33,903 Added 221.39%
49,217 $3.56 Million
Q2 2022

Aug 15, 2022

BUY
$87.2 - $114.05 $1.34 Million - $1.75 Million
15,314 New
15,314 $1.64 Million
Q1 2022

May 16, 2022

SELL
$94.19 - $124.49 $2.03 Million - $2.68 Million
-21,544 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$119.57 - $139.07 $2.2 Million - $2.55 Million
18,371 Added 578.98%
21,544 $2.76 Million
Q3 2021

Nov 15, 2021

SELL
$109.17 - $142.35 $343,557 - $447,975
-3,147 Reduced 49.79%
3,173 $422,000
Q2 2021

Aug 16, 2021

BUY
$100.34 - $115.69 $443,502 - $511,349
4,420 Added 232.63%
6,320 $683,000
Q1 2021

May 17, 2021

BUY
$101.51 - $125.27 $192,869 - $238,013
1,900 New
1,900 $200,000
Q4 2020

Feb 16, 2021

SELL
$85.88 - $105.36 $3.18 Million - $3.9 Million
-37,057 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$72.74 - $92.5 $2.14 Million - $2.73 Million
29,487 Added 389.52%
37,057 $3.17 Million
Q2 2020

Aug 17, 2020

BUY
$48.02 - $79.04 $363,511 - $598,332
7,570 New
7,570 $555,000
Q4 2019

Feb 14, 2020

SELL
$47.06 - $56.64 $1.54 Million - $1.85 Million
-32,627 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$47.45 - $58.05 $1.55 Million - $1.89 Million
32,627 New
32,627 $1.56 Million
Q2 2019

Aug 14, 2019

SELL
$39.26 - $54.21 $1.64 Million - $2.27 Million
-41,800 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$29.84 - $43.92 $1.25 Million - $1.84 Million
41,800 New
41,800 $1.7 Million
Q4 2018

Feb 14, 2019

SELL
$29.95 - $46.34 $1.27 Million - $1.97 Million
-42,409 Closed
0 $0
Q3 2018

Nov 01, 2018

BUY
$40.12 - $45.55 $997,262 - $1.13 Million
24,857 Added 141.62%
42,409 $1.93 Million
Q2 2018

Aug 03, 2018

BUY
$38.72 - $42.52 $679,613 - $746,311
17,552 New
17,552 $735,000
Q1 2018

May 07, 2018

SELL
$39.4 - $47.39 $679,295 - $817,050
-17,241 Closed
0 $0
Q4 2017

Feb 01, 2018

SELL
$37.27 - $43.02 $1.79 Million - $2.07 Million
-48,151 Reduced 73.63%
17,241 $708,000
Q3 2017

Nov 13, 2017

BUY
$33.75 - $41.67 $2.21 Million - $2.72 Million
65,392
65,392 $2.61 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.